+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Retinoblastoma Treatment Market 2020-2026

  • PDF Icon


  • June 2020
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 5129739
UP TO OFF until Dec 31st 2022
Global Retinoblastoma Treatment Market Size, Share & Trends Analysis Report By Treatment type (Surgery, Radiation therapy, Laser Therapy (Photocoagulation), Cryotherapy, Thermotherapy, and Chemotherapy), By Type of Retinoblastoma (Non-hereditary Retinoblastoma and Hereditary Retinoblastoma), and Forecast 2020-2026
The global retinoblastoma treatment market is anticipated to grow significantly during the forecast period. Retinoblastoma is a type of eye cancer which have highest prevalence in children younger than 2 years. Treatment for retinoblastoma includes the general treatments used in cancer such as chemotherapy, radiation therapy, laser therapy, surgery and many more.

The major factor contributing to the growth of the market include increasing awareness regarding the different type of cancer across the globe. Additionally, the recurrence of retinoblastoma will also drive the retinoblastoma treatment market significantly.

The global retinoblastoma treatment market is segmented on the basis of treatment type and type of retinoblastoma. Based on the treatment type, the market is sub-segmented into surgery, radiation therapy, laser therapy (photocoagulation), cryotherapy, thermotherapy, and chemotherapy. Further based on type of retinoblastoma the market is sub-segmented into non-hereditary retinoblastoma and hereditary retinoblastoma.

The global retinoblastoma treatment market is further segmented based on geography into North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), and the Rest of the World. North America is expected to hold significant share in the market during the forecast period. The growth in the region is due to the presence of well-developed healthcare sector especially for the cancer care. Some of the players of the global retinoblastoma treatment market include Hikma Pharmaceuticals Plc, Baxter International Inc., Merck & Co. Inc., Sanofi S.A., Pfizer Inc., and others.

Research Methodology

The market study of the global retinoblastoma treatment market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for the government organizations, pharmaceutical industry, hospitals& clinics, and other related organizations for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, products offered by the companies, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation:

1. Global Retinoblastoma Treatment Market Research and Analysis by Treatment Type
2. Global Retinoblastoma Treatment Market Research and Analysis by Type of Retinoblastoma

The Report Covers
  • Comprehensive research methodology of the global retinoblastoma treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global retinoblastoma treatment market.
  • Insights about market determinants which are stimulating the global retinoblastoma treatment market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Key Strategy Analysis
3.2. Key Company Analysis
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Retinoblastoma Treatment Market by Treatment Type
5.1.1. Surgery
5.1.2. Radiation therapy
5.1.3. Laser Therapy (Photocoagulation)
5.1.4. Cryotherapy
5.1.5. Thermotherapy
5.1.6. Chemotherapy
5.2. Global Retinoblastoma Treatment Market by Type of Retinoblastoma
5.2.1. Non-hereditary Retinoblastoma
5.2.2. Hereditary Retinoblastoma
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. AbbVie Inc.
7.2. Accuray Incorporated
7.3. Baxter International Inc.
7.4. Bristol-Myers Squibb Co.
7.5. Cadila Pharmaceuticals Ltd.
7.6. CryoConcepts LP.
7.7. GlaxoSmithKline plc
7.8. Hikma Pharmaceuticals PLC
7.9. Johnson & Johnson Services, Inc.
7.10. Merck & Co. Inc.
7.11. Novartis International AG
7.12. Pfizer Inc.
7.13. Sanofi S.A.
7.14. Teva Pharmaceutical Industries Ltd.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • AbbVie Inc.
  • Accuray Incorporated
  • Baxter International Inc.
  • Bristol-Myers Squibb Co.
  • Cadila Pharmaceuticals Ltd.
  • CryoConcepts LP.
  • GlaxoSmithKline plc
  • Hikma Pharmaceuticals PLC
  • Johnson & Johnson Services, Inc.
  • Merck & Co. Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.